Synthroid and Breast calcifications - a phase IV clinical study of FDA data

Summary:

Breast calcifications is reported as a side effect among people who take Synthroid (levothyroxine sodium), especially for people who are 50-59 old, also take Fosamax, and have Osteoporosis.

The phase IV clinical study analyzes which people have Breast calcifications when taking Synthroid. It is created by eHealthMe based on reports of 237,758 people who have side effects when taking Synthroid from the FDA, and is updated regularly.

What is Synthroid?

Synthroid has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. eHealthMe is studying from 249,198 Synthroid users. Check the latest studies of Synthroid.

What is Breast calcifications?

Breast calcifications (deposits of calcium that can be seen on a mammogram of the breast) is found to be associated with 274 drugs and 309 conditions by eHealthMe. Check the latest studies of Breast calcifications.

On Jul, 12, 2026

237,758 people reported to have side effects when taking Synthroid.
Among them, 94 people (0.04%) have Breast calcifications.

Could Synthroid cause Breast calcifications?

Among these 94 people:

What is the age of people who have Breast calcifications when taking Synthroid? *

What are other drugs people take besides Synthroid? *

What are other side effects people have besides Breast calcifications? *

Pain In Extremity: 45 people, 47.87%
Stress And Anxiety: 40 people, 42.55%
Fall: 39 people, 41.49%
Pain: 38 people, 40.43%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 37 people, 39.36%
Depression: 33 people, 35.11%
Injury: 32 people, 34.04%
Back Pain: 31 people, 32.98%
Spinal Osteoarthritis (joint cartilage loss in spine): 31 people, 32.98%
Osteonecrosis Of Jaw (death of bone of jaw): 29 people, 30.85%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 21 people, 22.34%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 15 people, 15.96%
Depression: 12 people, 12.77%
Osteopenia (a condition where bone mineral density is lower than normal): 11 people, 11.70%
Metastases To Bone (cancer spreads to bone): 10 people, 10.64%
Bone Density Abnormal: 10 people, 10.64%
Breast Cancer: 9 people, 9.57%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 8 people, 8.51%
Menopause (end of monthly cycles in women): 8 people, 8.51%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 7 people, 7.45%

* Approximation only. Some reports may have incomplete information.

Do you take Synthroid and have Breast calcifications?

- Check whether Breast calcifications is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Synthroid:

Synthroid (249,198 reports)

Browse all side effects of Synthroid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Breast calcifications:

Breast calcifications (274 drugs)

Browse all the conditions that are associated with Breast calcifications:

Breast calcifications (309 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on levothyroxine sodium (the active ingredients of Synthroid) and Synthroid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.